Panacea Biotech share price has zoomed 8% and is presently trading at Rs 144.0.
Meanwhile, the BSE HEALTHCARE index is at 37,866.5 (up 1.2%).
Among the top gainers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (up 11.9%) and Lupin (up 8.2%).
ERIS LIFESCIENCES (down 1.5%) and SUVEN PHARMACEUTICALS (down 1.2%) are among the top losers today.
Over the last one year, Panacea Biotech has moved up from Rs 126.0 to Rs 144.0, registering a gain of Rs 18.0 (up 14.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,866.5, registering a gain of 47.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Lupin (up 97.7%), Cadila Healthcare (up 97.1%) and Glenmark Pharma (up 96.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,049.7 (up 0.1%).
The top gainers among the BSE Sensex today are Tata Motors (up 2.7%) and HCl Tech. (up 2.7%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 24,304.7 (up 0.1%). Tata Motors and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 80,049.7, registering a gain of 14,844.6 points (up 22.8%).
Panacea Biotech net profit grew 84.3% YoY to Rs -20 million for the quarter ended March 2024, compared to a loss of Rs 127 million a year ago. Net sales rose 5.8% to Rs 1,365 million during the period as against Rs 1,289 million in January-March 2023.
For the year ended March 2023, Panacea Biotech reported 103.1% decrease in net profit to Rs -337 million compared to net profit of Rs 10,783 million during FY22. Revenue of the company fell 30.4% to Rs 4,599 million during FY23.
The current Price to earnings ratio of Panacea Biotech, based on rolling 12 month earnings, stands at -588.2.
Equitymaster requests your view! Post a comment on "Panacea Biotech Gains 8%; BSE HEALTHCARE Index Up 1.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!